Intervention Protocol

Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients

  1. Krishna M Karpe*,
  2. Girish S Talaulikar,
  3. Giles Walters

Editorial Group: Cochrane Renal Group

Published Online: 17 OCT 2007

DOI: 10.1002/14651858.CD006750


How to Cite

Karpe KM, Talaulikar GS, Walters G. Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD006750. DOI: 10.1002/14651858.CD006750.

Author Information

  1. The Canberra Hospital, Renal Department, Garran, ACT, Australia

*Krishna M Karpe, Renal Department, The Canberra Hospital, Yamba Drive, Garran, ACT, 2605, Australia. krishna.karpe@act.gov.au.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 OCT 2007

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

This review aims to look at the benefits and harms of calcineurin inhibitor tapering or withdrawal in terms of graft function and loss, incidence of acute rejection episodes, treatment-related side effects (hypertension, hyperlipidaemia) and mortality.